Prescription Drug Information: Lorazepam (Page 4 of 4)

Package/Label Display Panel – Carton- 0.5 mg

0.5 mg Lorazepam Tablets Carton
(click image for full-size original)

NDC 60687- 627 -01

Lorazepam     CIV
Tablets, USP

0.5 mg

100 Tablets (10 x 10)                Rx Only

PHARMACIST: Dispense with the accompanying Medication
Guide to each patient.

Each Tablet Contains:
Lorazepam, USP…………………………………………………………….0.5 mg

Usual Dosage: See package insert for full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Keep this and all drugs out of reach of children.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0093-3425, Teva Pharmaceuticals.

Distributed by:
American Health Packaging Columbus, Ohio 43217

762701

0462701/0222

Package/Label Display Panel – Blister – 0.5 mg

0.5 mg Lorazepam Tablet Blister
(click image for full-size original)

Lorazepam Tablet, USP    CIV

0.5 mg

Package/Label Display Panel – Carton – 1 mg

1 mg Lorazepam Tablets Carton
(click image for full-size original)

NDC 60687- 638 -01

Lorazepam     CIV
Tablets, USP

1 mg

100 Tablets (10 x 10)                 Rx Only

PHARMACIST: Dispense with the accompanying Medication
Guide to each patient.

Each Tablet Contains:
Lorazepam, USP……………………………………………………………….1 mg

Usual Dosage: See package insert for full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Keep this and all drugs out of reach of children.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0093-3426, Teva Pharmaceuticals.

Distributed by:
American Health Packaging
Columbus, Ohio 43217

763801 0463801/0622

Package/Label Display Panel – Blister – 1 mg

1 mg Lorazepam Tablet Blister
(click image for full-size original)

Lorazepam Tablet, USP    CIV

1 mg

Package/Label Display Panel – Carton – 2 mg

2 mg Lorazepam Tablets Carton
(click image for full-size original)

NDC 60687- 649 -01

Lorazepam     CIV
Tablets, USP

2 mg

100 Tablets (10 x 10)                 Rx Only

PHARMACIST: Dispense with the accompanying Medication
Guide to each patient.

Each Tablet Contains:
Lorazepam, USP………………………………………………………………. 2 mg

Usual Dosage: See package insert for full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

Keep this and all drugs out of reach of children.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0093-3427, Teva Pharmaceuticals.

Distributed by:
American Health Packaging
Columbus, Ohio 43217

764901 0464901/0522

Package/Label Display Panel – Blister – 2 mg

2 mg Lorazepam Tablet Blister
(click image for full-size original)

Lorazepam Tablet, USP    CIV

2 mg

LORAZEPAM lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:60687-627(NDC:0093-3425)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LORAZEPAM (LORAZEPAM) LORAZEPAM 0.5 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POLACRILIN POTASSIUM
Product Characteristics
Color white (white to off-white) Score no score
Shape ROUND Size 6mm
Flavor Imprint Code TV;0;5;5R
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:60687-627-01 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK (60687-627-11)
1 NDC:60687-627-11 1 TABLET in 1 BLISTER PACK This package is contained within the CARTON (60687-627-01)
Image of Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072926 03/15/2022
LORAZEPAM lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:60687-638(NDC:0093-3426)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LORAZEPAM (LORAZEPAM) LORAZEPAM 1 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POLACRILIN POTASSIUM
Product Characteristics
Color white (white to off-white) Score 2 pieces
Shape ROUND Size 7mm
Flavor Imprint Code TV;1;1;R
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:60687-638-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (60687-638-11)
1 NDC:60687-638-11 1 TABLET in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (60687-638-01)
Image of Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072927 03/25/2022
LORAZEPAM lorazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:60687-649(NDC:0093-3427)
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LORAZEPAM (LORAZEPAM) LORAZEPAM 2 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
POLACRILIN POTASSIUM
Product Characteristics
Color white (white to off-white) Score 2 pieces
Shape ROUND Size 7mm
Flavor Imprint Code TV;2;2;R
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:60687-649-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (60687-649-11)
1 NDC:60687-649-11 1 TABLET in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (60687-649-01)
Image of Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA072928 10/07/2021
Labeler — American Health Packaging (929561009)
Establishment
Name Address ID/FEI Operations
American Health Packaging 929561009 repack (60687-627), repack (60687-638), repack (60687-649)

Revised: 06/2022 American Health Packaging

Page 4 of 4 1 2 3 4

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.